2024 International Congress Archives - Page 103 of 181

RAB32 c.213C>G (p.Ser71Arg) explains Parkinson’s disease in two UK families: description of the clinical and biochemical features

R. Tilney, R. Real, E. Gustavsson, S. Jasaityte, Y. Kordovska, M. Fenn, P. Korlipara, M. Hu, E. Sammler, M. Farrer, H. Morris (London, United Kingdom)
RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD)

C. Beetz, M. Radefeldt, K. Tripolszki, P. Bauer (Rostock, Germany)
Racial Disparities in Hospitalization Characteristics among Native Hawaiians, Pacific Islanders and Asian American Subgroups with Restless Legs Syndrome

L. Terpak, M. Matsunaga, E. Krening, M. Bruno (Honolulu, USA)
Radiofrequency Lesioning for hemidystonia: a systematic review

A. Abdulbaki, A. Jijakli, P. Doshi, J. Krauss (Hannover, Germany)
Randomized Controlled Trial of Supplementary Motor Area Transcranial Direct Current Stimulation in Tourette Syndrome

Y. Mahjoub, N. Szejko, L. Gan, J. Adeoti, M. Nitsche, C. Vicario, T. Pringsheim, D. Martino (Calgary, Canada)
Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study

XY. Li, G. Tang, FT. Liu, J. Wang (Shanghai, China)
Rapid Onset Kinematic Effects of Thalamic/Subthalamic DBS in Cervical Dystonia

T. Hart, A. Sadnicka, I. Cociasu, L. Ricciardi, F. Baig, M. Hart, M. Edwards, E. Pereira, F. Morgante (London, United Kingdom)
Rapidly Progressive Pallidopyramidal Syndrome related to Parkin gene mutation

F. Mustafa, A. Elavarasi, D. Vibha, R. Singh, J. Parihar, M. Tripathi, A. Das (Calicut, India)
Rare Clinical Manifestation of Tardive Dyskinesia In Schizophrenic Patient on Quetiapine and Sertraline: A Case Report

H. Oktaviani, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)
Rare Missense Variants in KCNJ10 Are Associated with Paroxysmal Kinesigenic Dyskinesia

T. Wirth, E. Roze, C. Delvallée, O. Trouillard, N. Drouot, P. Damier, C. Boulay, M. Bourgninaud, P. Jegatheesan, A. Sangare, S. Forlani, B. Gaymard, R. Hervochon, V. Navarro, N. Calmels, A. Schalk, C. Tranchant, A. Piton, A. Méneret, M. Anheim (Strasbourg, France)
Rare Variant Association Analysis in Kazakhstani Parkinson’s Disease Population: Preliminary Results from GP2 CAT-PD Study

M. Isayan, N. Zharkinbekova, S. Abdraimova, CH. Shashkin, ZH. Myrzayev, V. Akhmetzhanov, A. Karimova, M. Ganieva, Z. Tavadyan, S. Khachatryan, M. Beridze, S. Sopromadze, I. Khatiashvilli, M. Kekenadze, K. Ceferov, V. Escott-Price, J. Hardy, H. Houlden, R. Kaiyrzhanov (Yerevan, Armenia)
Rare Variant Burden is Increased in Sporadic Late-onset Chinese Parkinson’s Disease Patients

RWH. Ho, ZW. Xiong, RCN. Lo, HF. Liu, PWL. Ho, SL. Ho, SYY. Pang (Hong Kong, Hong Kong)
Rationale and Design of the Slowing Parkinson’s Early through Exercise Dosage – United Kingdom (Slow-SPEED-UK) Trial

E. Mitchell (London, United Kingdom)
Rationale for LRRK2 inhibition in sporadic Parkinson’s disease and the LUMA trial

R. Hauser, A. Lang, L. Kalia, JT. Greenamyre, R. Llorens-Arenas, D. Jennings, B. Hersh, K. Fraser, S. Huntwork-Rodriguez, A. Henry, J. Kluss, C. Paisán-Ruiz, Z. Berger (Tampa, USA)
Raynaud’s Phenomenon and Diaphoresis During Initial Programming of Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease: A Case Report

A. Camargo, S. Akkus, J. Jimenez Shahed (Harstdale, USA)
RBD Unmasked: LRRK2 and the Prodromal Path to Parkinson’s Disease

M. Acharya, S. Datta, N. Ghosh, B. Chakraborty (Kharagpur, India)
Reaching Kinematics in Movement Disorder Patients Using an Open-Source Computer Vision Technology

AB. Bayen, S. Majumdar, S. Choudhury, J. Ganguly, P. Basu, S. Dey, M. Baker, S. Baker, H. Kumar (Kolkata, India)
Readiness for genetic testing among Indian movement disorder patients:A tertiary centre experience

S. Kamath, V. Holla, N. Kamble, R. Mahale, R. Yadav, P. Pal (Bangalore, India)
Real-life experience of switching from D-penicillamine to trientine tetrahydrochloride – a nationwide registry study

A. Poujois, MA. Obadia, N. Oussedik-Djebrani, E. Couchonnal-Bedoya, D. Debray (PARIS, France)
Real-Time Removal of Stimulus Artifact for Closed-Loop Deep Brain Stimulation by Synchronized Sample-And-Hold Artifact Blanking (SSAB): Verification in Animal Model

YH. Wu, HC. Lin, CW. Huang, CC. Hsieh, MD. Ker (Hsinchu City, Taiwan)
Real-World Clinical and Safety Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients

G. Deuschl, R. Schuurman, G. Loret, N. Kovacs, M. Barbe, M. Blázquez Estrada, F. Clement, J. Lee, S. Jaumà Classen, D. Pedrosa, J. Volkmann, A. Oliveira, S. Paschen, L. Chen, E. Goldberg (Kiel, Germany)
Real-World Diagnosis of Chronic Migraine in Patients With Cervical Dystonia Analyzed by Botulinum Neurotoxin Treatment Exposure: an Epidemiologic Perspective

R. Rodriguez, S. Broner, G. Forde, C. Rhyne, M. Sadeghi, E. Yue, A. Ukah, K. Becker Ifantides, H. Sarva (Orlando, USA)
Real-world Experiences of Image-guided Programming in Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease

J S. Lee, J. Ha, J W. Cho, J. Lee, J. Youn (Daegu, Republic of Korea)
Real-World Multicenter Analysis of Levodopa Equivalent Daily Dosage Algorithms- Capturing Geographical and Demographic Disparities in Parkinson’s Disease Therapy Spanning Six Countries and Two Continents

P. Kukkle, L. Kalia, A. Habib, P. Jagota, R. Ojha, R. Kandadai, S. Desai, M. Caldera, D. Sirisena, D. Garg, T. Mestre, R. Neupane, S. Maytharakcheep, K. Sanyawut, R. Borgohain (Bangalore, India)
Real-world Programming and Sensing from Adaptive Deep Brain Stimulation for Parkinson’s Disease in Japan

G. Oyama, K. Kimura, H. Kishima, N. Murase, Y. Tsuboi, T. Tsuboi, T. Takezaki, Y. Higuchi, T. Hashimoto, Y. Shimo, T. Brionne, I. Buffin, K. Hidaka, F. Coletti, R. Amit, N. Morelli, H. Mure, H. Oshima (Tokyo, Japan)
Real-World Retrospective Safety Analysis in Patients Treated With OnabotulinumtoxinA for Multiple Therapeutic Indications Over Repeat Treatment Periods

G. Forde, A. Patel, K. Martinez, A. Mayadev, B. Brucker, T. Brown, Z. Ayyoub, R. Singh, M. Nelson, A. Ukah, I. Yushmanova, S. Battucci, K. Becker Ifantides, C. Rhyne (New Hyde Park, USA)
Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?

A. Martinez Nunez, N. Walker-Pizarro, A. Wagle Shukla, A. Ramirez-Zamora, N. Mcfarland (Gainesvile, USA)
Recrudescence of a Compensated Hemidystonia-hemiatrophy Syndrome After COVID-19 Infection

A. Kundrick, H. Fernandez (Cleveland, USA)
Recruitment of Ethnoracially Diverse Participants for Disease-Modifying Drug Trials in Parkinson’s Disease: Are We Doing It Right? A Systematic Review and Meta-Analysis.

F. Reis Rodrigues, E. Pasqualotto, G. Ribeiro, J. M. Couto, E. Bayram, M. Ushe, D. Di Luca (Vicosa, Brazil)
Reduced intestinal inflammation and increased levels of short-chain fatty acids thanks to an active lifestyle in Parkinson’s disease.

NES. Chtioui, CHR. Duval, DAV. St-Pierre (Montreal, Canada)
Reduced parietal and sensorimotor cortex recruitment during complex gait in Parkinson’s disease patients with freezing of gait

N. D'Cruz, M. Goris, C. Mccrum, A. Nieuwboer, M. Gilat (Leuven, Belgium)
Reduced plasma levels of various cell signaling molecules in patients with Parkinson’s Disease

S. Zadegan, A. Teixeira, E. Furr Stimming, N. Pessoa Rocha (Housotn, USA)
Reduced Thalamic Nuclei Volume May Contribute to Anxiety in Parkinson’s Disease: a 7-Tesla MRI Study

G. Carey, M. Kuijf, S. Michielse, A. Wolters, K. Dujardin, A. Leentjens (Lille, France)
Refining Aesthetic Eyebrows: Botulinum Toxin Injection for Hemifacial Spasm.

S. Maytharakcheep, R. Bhidayasiri, O. Phokaewvarangkul (Bangkok, Thailand)
Refining and Understanding Causal Relationships between Brain Imaging-Derived Phenotypes and Parkinson’s Disease: a Bidirectional Mendelian Randomization Study and Clinical Validation

M. Niu, Y. Zhang (Shanghai, China)
REGENERATE-PD: A Phase 2, Randomized, Double-Blind, Surgery-Controlled Study of GDNF Gene Therapy (AAV2-GDNF; AB-1005) for Moderate Stage Parkinson’s Disease

A. Whone, C. Christine, M. Luz, R. Richardson, C. Urrea, N. Chhabria, C. Letourneau, M. Wisniewski, M. Fiandaca, A. van Laar, A. Kells, K. Bankiewicz (Bristol, United Kingdom)
Regional Brain Volume Differences Across PD Clinical Subtypes

A. Eid, S. Grossen, A. Tanenbaum, J. Hood, H. Hwang, T. Cash, C. Lessov-Schlaggar, P. Kotzbauer, J. Perlmutter, M. Campbell (SAINT LOUIS, USA)
Regional tau burden patterns and their associations with clinical severity in progressive supranuclear palsy (PSP)-Richardson’s syndrome and PSP- predominant parkinsonism: a prospective cohort study

R. Kim, S. Lee, Y. Kim, B. Jin, S. Kim, H. Kim, S. Shin, H. Kim, J. Lee (Seoul, Republic of Korea)
Relationship Between Non-Motor Symptoms, Kinematic Features, and Quality of Life in Cervical Dystonia

T. Hart, L. Heideman, D. Martino, M. Beudel, A. Sadnicka, F. Morgante (London, United Kingdom)
Relationships of blood Vitamin B12 and Homocysteine with Parkinson’s Disease Progression in 3 Contemporary Clinical Trials

C. Christine, P. Auinger, E. Forti, L. Tat, N. Cannizzaro, D. Oakes, R. Green (San Francisco, USA)
Reliability and Validity of the English Version of the Parkinson Anxiety Scale

J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)
Reliability of Digital Measures in Parkinson’s Disease and Their Implications for Sample Size Calculations

J. Lavine, A. Scotina, S. Haney, E. Izmailova, L. Omberg (New York, USA)
Reliability of neurophysiological and cerebral tremor features in Parkinson’s disease

L. Angelini, KRE. Berg, MF. Dirkx, M. Bologna, BR. Bloem, RCG. Helmich (Pozzilli
Reliability of real-world walking activity and gait assessment in people with Parkinson’s disease – how many hours and days are needed?

J. Buekers, J. Marchena, S. Koch, J. Lemos, J. Cherdova, C. Becker, T. Bonci, J. Braun, B. Caulfield, A. Frei, E. Gazit, J. Hausdorff, A. Mirelman, S. Del Din, L. Alcock, A. Yarnall, C. Jansen, M. Long, B. Sharrack, D. Singleton, C. Schlenstedt, W. Maetzler, H. Gassner, A. Ionescu, P. Ginis, A. Nieuwboer, L. Rochester, J. Garcia-Aymerich (Barcelona, Spain)
REM sleep behavior disorder and Prodromal Parkinson’s Disease in patients with Essential Tremor

P. Bugalho, B. Meira, A. Pinho, R. Ventura, M. Magriço, M. Serôdio, D. Krupka, V. Ferreira (Lisboa, Portugal)
Remote Digital Longitudinal Assessment of Speech, Fluency and Cognitive Function in Progressive Supranuclear Palsy

A-M. Wills, R. Mishra, M. Sharma, V. Zhao, C. Isroff, AJ. Hall, J. Casado, A. Nunes, R. Cole, A. Vaziri, A. Pantelyat (Boston, USA)
Remote DNA Collection for Parkinson’s Research: Insights from AccessPD

Y-H. Chang, E. Shelton, H. Chohan, M. Periñan, A. Noyce (London, United Kingdom)
Remote monitoring of upper limb function in Huntington’s disease using a wearable sensor

J. Adams, A. Nunes, R. Mishra, E. Dorsey, A. Vaziri (Rochester, USA)
Remote recruitment of hyposmic participants identifies biomarkers related to neuronal alpha-synuclein disease

E. Brown, A. Siderowf, T. Simuni, T. Sherer, M. Brumm, C. Caspell-Garcia, R. Kurth, C. Gochanour, M. Marshall, M. Korell, C. Stanley, L. Concha, C. Soto, K. Marek, C. Tanner (San Francisco, USA)
Remotely-deployed gamification intervention to increase physical activity in Parkinson’s Disease

K. Waddell, M. Smith, S. Wood, R. Greysen, J. Morley (Philadelphia, USA)
Repurposing Anti-Gout Medications for the Treatment of Parkinson’s Disease

R. Hughes, O. Bandmann, L. Ferraiuolo, H. Mortiboys (Sheffield, United Kingdom)
Research Information Disclosure In The PPMI Study: Development Of A Disclosure Process

T. Tropea, J. Schulze, C. Destro, L. Heathers, B. Henry, JM. Talarico, C. Stanley, M. Mcguire Kuhl, E. Flagg, T. Foroud (Philadelphia, USA)
Responders to a Highly Challenging Balance and Gait Intervention in People with Parkinson’s Disease

E. Franzén, H. Johansson, E. Westman, M. Hagströmer, F. Albrecht (Stockholm, Sweden)
Response inhibition in patients with Lithium induced Tremor

S. Banerjee, S. Choudhury, S. Majumdar, A. Bayen, P. Jakati, M. Baker, S. Baker, H. Kumar (KOLKATA, India)
Responsive morphometric fingerprints in deep brain stimulation for Parkinson’s disease

Y. Lai, Y. Pan, N. He, P. Huang, F. Wang, C. Ying, M. Hnazaee, C. Cao, V. Voon, B. Sun, F. Yan, D. Li (Shanghai, China)
Resting state EEG source analysis identifies distinct neural signature associated with impulse control disorders in PD

E. Iglesias-Camacho, FJ. Gómez Campos, P. Franco Rosado, L. Garrote Espina, AM. Castellano-Gerrero, M. San Eufrasio, C. Perez-Calvo, L. Muñoz-Delgado, S. Jesús, D. Macías-García, E. Ojeda-Lepe, A. Adarmes-Gómez, F. Carrillo, JF. Martín-Rodriguez, P. Mir (Seville, Spain)
Resting-State Network Alterations in Patients with Isolated REM Sleep Behavior Disorder and their Association with Clinical Symptoms

I. Roura, J. Pardo, J. Oltra, A. Campabadal, Y. Compta, N. Bargallo, M. Serradell, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)
Retention Strategies in Parkinson’s Disease Clinical Studies: Findings From a Scoping Review of Recruitment and Retention Strategies

R. Petty, V. Agarwal, J. Allison, S. Bartolomeu Pires, M. Bartlett, T. Boey, R. Croucher, H. Collins, S. Collins, E. Davies, J. Duffen, R. Ellis-Doyle, C. Gonzalez-Robles, F. Hudson, J. Inches, L. Miller, G. Mills, S. Wonnacott, T. Foltynie, C. Carroll, S. Mullin, M. Zeissler (Plymouth, United Kingdom)
Reversible Hemichorea-Hemiballismus-Hemifacial Spasm in Diabetic Striatopathy

D. Das, A. Singh, J. Singhvi (Mohali, India)
Reversing the irreversible: The application of Deep Brain Stimulation in The Syndrome of Irreversible Lithium Effectuated Neurotoxicity.

L. Okar, P. Murin, A. Prabhune, C. Pratap (St.Louis, USA)
Revitalizing Lives: The Dystonia Care Rehabilitation Program

A. Zawar (Lynnwood, USA)
Risk Factors Of Parkinson’s Disease A Case-Control Study In Tunisian Patients

S. Sellami, N. Farhat, KS. Moalla, N. Bouattour, S. Daoued, S. Sakka, M. Damak, C. Mhiri (Sfax, Tunisia)
Risk Tolerance of Therapeutic Interventions in People with Parkinson’s Disease

B. Dukes, A. Colombo, K. Patel, D. Shah-Zamora (Winston Salem, USA)
Role of RNA splicing in Parkinson’s disease

K. Irmady, C. Hale, R. Qadri, J. Fak, T. Carroll, R. Darnell (New York, USA)
Role of Telemedicine- Versus Outpatient-Based Initiation And Management of Atkins Diet Therapy In Postmenopausal Women With Drug-Resistant Parkinson’s Disease During The COVID-19 Pandemic

M. Sharma, S. Sinha (Pimpri, India)
Role of the Alpha-synuclein Seed Amplification Assay in Parkinson’s Disease Clinical Trials: A Case Report of Multiple System Atrophy Misdiagnosed as Parkinson’s Disease

E. Tharp, J. Martinez-Lemus, J. Suescun, C. Adams, M. Shahnawaz, T. Ellmore, M. Schiess (Houston, USA)
Role of Wearable Devices in a Physical Activity Coaching Program for People with Parkinson Disease

A. Pacheco, K. Long, D. Wani, J. Alomar, D. Kipnis, C. Macpherson (NYC, USA)
Rora deficiency aggravates dopamine neurons loss via reducing NAD+ level in Parkinson’s disease

JW. Li, HS. Liu, XY. Hu, T. Wang, N. Xiong (Wuhan, China)
Rural Tanzania’s Wide “PD Gap” Through the Decades

M. Dekker, S. Urasa, W. Howlett, R. Morton, J. Josephat, R. Walker (Moshi, United Republic of Tanzania)